Filter Results:
(5,081)
Show Results For
- All HBS Web
(5,081)
- People (18)
- News (1,638)
- Research (2,745)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,756)
Show Results For
- All HBS Web
(5,081)
- People (18)
- News (1,638)
- Research (2,745)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,756)
- 03 Sep 2015
- News
Lahey, Beth Israel Deaconess in merger talk
- June 2017
- Case
Obesity Management at Kaiser Permanente: A New Mindset for Healthcare Delivery?
By: Kevin Schulman, Gregory Leya and Christina Beveridge
Kaiser Permanente (KP) is the largest managed care organization in the United States with over 10 million members. KP evolved from a prepayment or capitation model that focuses the organization around the efficiency of care and the health of the population it serves.... View Details
Keywords: Operations; Health Care and Treatment; Business Model; Strategy; Health Industry; United States
Schulman, Kevin, Gregory Leya, and Christina Beveridge. "Obesity Management at Kaiser Permanente: A New Mindset for Healthcare Delivery?" Harvard Business School Case 317-106, June 2017.
- 23 Sep 2013
- News
The Best Biotech Graduate Schools in Real Life
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
markets have tightened, it's the companies with highly differentiated products that will be able to not only weather this storm, but come out the other side" in a strong position, says Harvard Business... View Details
- 18 Apr 2013
- Working Paper Summaries
The Impact of Pooling on Throughput Time in Discretionary Work Settings: An Empirical Investigation of Emergency Department Length of Stay
- August 2007 (Revised November 2008)
- Case
Biocon: Launching a New Cancer Drug in India
By: Sunil Gupta and Das Narayandas
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India. View Details
Keywords: Price; Health Care and Treatment; Marketing Strategy; Product Launch; Planning; Biotechnology Industry; Pharmaceutical Industry; India
Gupta, Sunil, and Das Narayandas. "Biocon: Launching a New Cancer Drug in India." Harvard Business School Case 508-026, August 2007. (Revised November 2008.)
- October 2009 (Revised January 2010)
- Case
The Joslin Diabetes Center
By: Michael E. Porter, Elizabeth Olmsted Teisberg and Scott Wallace
The Joslin Diabetes Center in Boston, Massachusetts is a leading center for diabetes care, clinician training, and research. The incidence of diabetes is rising precipitously worldwide, challenging quality of life with its complications and rapidly accelerating health... View Details
Keywords: Integration; Service Delivery; Medical Specialties; Health Care and Treatment; Outcome or Result; Corporate Finance; Health Industry; Boston
Porter, Michael E., Elizabeth Olmsted Teisberg, and Scott Wallace. "The Joslin Diabetes Center." Harvard Business School Case 710-424, October 2009. (Revised January 2010.)
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
'86). She is global marketing director at Baxter Healthcare. She recalled that while living in the United Kingdom, her children started a lemonade stand but few potential customers even gave it a second... View Details
- January 2017
- Case
SoulCycle
By: David Collis, Eric Van den Steen and Ashley Hartman
Co-founders Julie Rice and Elizabeth Cutler have grown SoulCycle from a business idea in 2006 to a major presence among urban boutique fitness studios in 2015. In March 2015, fitness company Equinox approaches them with an offer to buy them out. Evaluating the offer... View Details
Keywords: SoulCycle; Flywheel; Spinning; Indoor Cycling; Boutique Fitness; Fitness; Health Clubs; Community Engagement; Strategy; Business Strategy; Corporate Strategy; Expansion; Competitive Advantage; Competitive Strategy; Segmentation; Health Industry; Health Industry
Collis, David, Eric Van den Steen, and Ashley Hartman. "SoulCycle." Harvard Business School Case 717-454, January 2017.
- June 2006 (Revised June 2007)
- Background Note
The Challenge Facing the U.S. Healthcare Delivery System
By: Richard M.J. Bohmer and Carin-Isabel Knoop
Discusses the challenges currently facing the U.S. health care delivery system. These challenges frame the problems managers of delivery organizations are currently facing. They include a burgeoning gap between demand and supply. Demand for health care services is... View Details
Bohmer, Richard M.J., and Carin-Isabel Knoop. "The Challenge Facing the U.S. Healthcare Delivery System." Harvard Business School Background Note 606-096, June 2006. (Revised June 2007.)
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- 15 Feb 2018
- News
Does CVS–Aetna Spell the End of Business as Usual?
- 28 Nov 2006
- News
Singapore's Healthcare System Moving in Right Direction
- February 2022 (Revised April 2022)
- Case
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Tuna Cem Hayirli
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant. The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
Keywords: COVID; Caregiving; Healthcare; Access; Change; Retail; Health; Health Care and Treatment; Organizational Change and Adaptation; Transformation; Health Industry; Health Industry
Kanter, Rosabeth Moss, and Tuna Cem Hayirli. "CVS Health: Prescription for Transformation." Harvard Business School Case 322-091, February 2022. (Revised April 2022.)
- 01 Aug 2020
- News
"In a Hurry from a Young Age"
- 25 Feb 2025
- Blog Post
Making a Broader Impact with Multiple Disciplines: Santosh Iyer (MBA 2020)
engaging college students in hackathons to tackle real-world challenges, and equipping industry professionals with AI workshops that drive health care innovation. By spanning... View Details
- 11 Dec 2014
- News
Boston Medical Center, Tufts in merger talks
- November 2020 (Revised March 2021)
- Case
Sercomm: Operating in China Amid COVID-19 and Beyond
By: Prithwiraj Choudhury, Gary P. Pisano and Bonnie Yining Cao
The COVID-19 pandemic had forced a production cut in the factory of Sercomm, one of the world’s major telecom equipment producers, in China. The case explores and highlights the challenges that Chief Executive Officer James Wang faced: How could Sercomm recover and... View Details
Keywords: Emerging Markets; Information Technology; Operations; Management; Health Pandemics; Strategy; Telecommunications Industry; Manufacturing Industry; China
Choudhury, Prithwiraj, Gary P. Pisano, and Bonnie Yining Cao. "Sercomm: Operating in China Amid COVID-19 and Beyond." Harvard Business School Case 621-005, November 2020. (Revised March 2021.)
- September 2023 (Revised September 2023)
- Teaching Note
Roche: Innovation and Access to Healthcare
By: George Serafeim
Teaching Note for HBS Case No. 123-075. In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to... View Details
- May 2011
- Article
Nonsimultaneous Chains and Dominos in Kidney Paired Donation—Revisited
By: Itai Ashlagi, Duncan S. Gilchrist, Alvin E. Roth and Michael A. Rees
Since 2008 kidney exchange in America has grown in part from the incorporation of non-directed donors in transplant chains rather than simple exchanges. It is controversial whether these chains should be performed simultaneously ("domino paired donation," DPD) or... View Details
Keywords: ABO Incompatibility; Allosensitization; Paired Kidney Exchange; Regional Sharing; Simulation Models; Transplantation Policy; Health Care and Treatment; Supply Chain; Risk and Uncertainty; Logistics; United States
Ashlagi, Itai, Duncan S. Gilchrist, Alvin E. Roth, and Michael A. Rees. "Nonsimultaneous Chains and Dominos in Kidney Paired Donation—Revisited." American Journal of Transplantation 11, no. 5 (May 2011): 984–994.